Medline Inc. (MDLN)
NASDAQ: MDLN · Real-Time Price · USD
47.51
-1.38 (-2.82%)
At close: Feb 27, 2026, 4:00 PM EST
47.69
+0.18 (0.38%)
After-hours: Feb 27, 2026, 7:56 PM EST

Medline Stock Forecast

Stock Price Forecast

The 23 analysts with 12-month price forecasts for Medline stock have an average target of 49.74, with a low estimate of 40 and a high estimate of 60. The average target predicts an increase of 4.69% from the current stock price of 47.51.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $40 $49.74 $49 $60
Change -15.81% +4.69% +3.14% +26.29%

Analyst Ratings

The average analyst rating for Medline stock from 23 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Jan '26Feb '26
Strong Buy 78
Buy 1212
Hold 33
Sell 00
Strong Sell 00
Total 2223

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Wells Fargo
Wells Fargo
Hold
Maintains
$42$47
Hold Maintains $42$47 -1.07% Feb 27, 2026
Citigroup
Citigroup
Strong Buy
Maintains
$48$60
Strong Buy Maintains $48$60 +26.29% Feb 26, 2026
UBS
UBS
Strong Buy
Maintains
$48$57
Strong Buy Maintains $48$57 +19.97% Feb 26, 2026
BMO Capital
BMO Capital
Buy
Maintains
$45$54
Buy Maintains $45$54 +13.66% Feb 26, 2026
RBC Capital
RBC Capital
Buy
Maintains
$47$53
Buy Maintains $47$53 +11.56% Feb 26, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
31.17B
from 28.43B
Increased by 9.62%
Revenue Next Year
33.51B
from 31.17B
Increased by 7.53%
EPS This Year
1.50
from 1.43
Increased by 4.53%
EPS Next Year
1.66
from 1.50
Increased by 11.09%
Fiscal Year FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
21.45B23.23B25.51B28.43B31.17B33.51B
Revenue Growth
-8.31%9.80%11.47%9.62%7.53%
EPS
-0.010.071.431.501.66
EPS Growth
--413.80%1,982.77%4.53%11.09%
Forward PE
----31.7628.59
No. Analysts ----2626
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20262027
High 32.5B 35.5B
Avg 31.2B 33.5B
Low 29.5B 31.7B

Revenue Growth

Revenue Growth 20262027
High
14.4%
13.8%
Avg
9.6%
7.5%
Low
3.9%
1.7%

EPS Forecast

EPS 20262027
High 1.60 1.82
Avg 1.50 1.66
Low 1.20 1.33

EPS Growth

EPS Growth 20262027
High
11.5%
21.4%
Avg
4.5%
11.1%
Low
-16.4%
-10.8%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.